Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3043 of 6351
-
Magnetic helmet shows promise for long COVID brain fog in small study
Symptom relief CompletedThe purpose of this study is to assess the feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to PASC, and to collect data on safety and efficacy to inform the design of larger clinical studies. A prospective randomized controlled study of 30 p…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Online course lifts caregiver mood in just 30 days
Symptom relief CompletedThe goal of this study is to learn if a new online training program is helpful to dementia family caregivers. This online program is fully computerized and supports 24/7 access from any location. The main questions it aims to answer are: * Does the training program improves the …
Phase 2 • Sponsor: Education University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
New hope for tough myeloma: first human trial of JNJ-87562761 begins
Disease control OngoingThe purpose of this study is to determine the recommended phase 2 dose(s) (RP2D\[s\]) of JNJ-87562761 in Part 1 (dose escalation), and to determine the safety and tolerability at RP2D in Part 2 (dose expansion) in participants with multiple myeloma (MM) whose disease has come bac…
Phase 1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New study aims to cut arthritis flares by tailoring drug tapering
Disease control Recruiting nowRheumatoid arthritis (RA) is the most common inflammatory joint disorder. Since twenty year and the use of synthetic disease-modifying anti-rheumatic drugs (csDMARDs) and biological (b)DMARD, remission can be reached. When remission is obtained, the physician has no recommendatio…
Phase 4 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New ointment shows promise for eczema sufferers
Symptom relief CompletedThe goal of this clinical trial is to learn if CGB-500 works to treat atopic dermatitis in participants ages 12 and older. The goal is also to learn about the safety of CGB-500. The main questions it aims to answer are: Does CGB-500 improve atopic dermatitis by decreasing the ar…
Phase 2 • Sponsor: CAGE Bio Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
AI home coach helps kids master tricky 'R' sounds
Symptom relief Recruiting nowSpeech Sound Disorder (SSD) affects a significant portion of school-aged children, leading to social and emotional challenges that can persist into adolescence and adulthood. The number of productions necessary for a remediated speech sound to generalize to connected speech is ch…
Phase 2 • Sponsor: New York University • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Text therapy shows promise for anxious young adults
Symptom relief CompletedThe purpose of the proposed study is to test the feasibility and efficacy of a "anxiety-focused" text-delivered counseling program to reduce anxiety symptoms among young adults (18-25) with elevated anxiety symptoms. We are primarily interested in whether the intervention will re…
Sponsor: The University of Tennessee, Knoxville • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New Three-Drug cocktail targets untreated leukemia in early trial
Disease control PausedThis phase I trial tests safety, side effects and best dose of iadademstat with azacitidine and venetoclax for the treatment of patients with acute myeloid leukemia (AML) who have not received treatment (treatment naive). Chemotherapy drugs, such as iadademstat and azacitidine wo…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New TB vaccine put to the test in unique aerosol challenge study
Knowledge-focused OngoingThe purpose of this study is to: 1. Demonstrate the safety of a novel TB vaccine (ID93/GLA-SE) when given to both BCG-vaccinated and BCG-naïve volunteers. 2. Provide preliminary immunogenicity data of this novel TB vaccine (ID93/GLA-SE). This clinical trial will apply an aeroso…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
New study tests simple tools to boost COVID-19 shots in minority communities with arthritis
Knowledge-focused Recruiting nowThe overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Could a spinal cord device ease stubborn leg pain in diabetes and PAD?
Symptom relief Recruiting nowPeripheral arterial disease (PAD) affects over 230 million adults worldwide and is a highly morbid, costly, and disabling condition. Ischemic leg pain drives disability in PAD patients and results from oxygen supply-demand mismatch, autonomic dysfunction, and muscle breakdown. Th…
Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New program aims to keep cancer patients on treatment by spotting side effects sooner
Symptom relief Recruiting nowTo evaluate the rate of therapy discontinuation due to toxicity (side effects) among participants with cancer using ApricityCare. Investigators want to learn if identification of early clinical signs of irAEs with timely treatment can prevent severity progression and reduce trea…
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
MS drug ocrelizumab gets a Needle-Free makeover: new shot form tested
Disease control OngoingThe main purpose of this study is to evaluate the safety and tolerability of the ocrelizumab subcutaneous (SC) test formulation in participants with multiple sclerosis (MS). The study consists of two treatment phases: a dose-escalation and dose-continuation phase. Participants wi…
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Crossword puzzles tested as brain booster for memory loss
Symptom relief Recruiting nowEffective, clinically meaningful treatments are lacking for patients with mild cognitive impairment (MCI), which is associated with increased risk of transition to dementia. Cognitive training represents an important therapeutic strategy. In a previous study, crossword puzzles we…
Phase 2 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Can trauma be inherited? scientists launch major study on families after tragedy
Knowledge-focused Recruiting nowCARE 13-11 study explores the transmission of trauma within families. Exposure to a traumatic event can have an impact on those directly exposed, but also on their family. This transmission is both biological and behavioral, leading to adaptation that is still poorly understood.…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Happiness therapy: new study aims to ease anxiety in transplant survivors
Symptom relief Recruiting nowThis randomized clinical trial is evaluating the impact of a positive psychology intervention (PATH) on anxiety symptoms, depression symptoms, and quality of life in survivors of hematopoietic stem cell transplant (HSCT) compared to usual care.
Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New cancer drug SKB571 enters first human tests
Disease control Recruiting nowThis is a first-in-human (FIH), phase 1, multicenter, open-label study of SKB571 to evaluate the safety, tolerability, PK, immunogenicity, and antitumor activity in adult subjects with advanced or metastatic solid tumor .
Phase 1 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug HRS-6208 tested in advanced cancer patients
Disease control Recruiting nowThis is an open, multicenter Phase I study to evaluate the safety and tolerability of HRS-6208 in patients with advanced solid tumors.
Phase 1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Blood test may speed up deadly fungal infection diagnosis
Diagnosis CompletedInvasive fungal infections (IFI) are a major concern for immunocompromised or vulnerable patients. Associated mortality is significant and depends on the timeliness of diagnostic and therapeutic management. Consequently, biomarkers play a key role in therapeutic strategies compar…
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
Toman fish supplement tested to boost albumin in TB patients
Disease control OngoingThis study evaluates the potential of I-FALMIN, a supplement derived from toman fish (Channa micropeltes), as an additional source of albumin in patients with pulmonary tuberculosis. Tuberculosis patients often experience low albumin levels, which may slow down recovery. The purp…
Sponsor: Hasanuddin University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC